Susan Dana Jones Talaris Therapeutics, Inc. (TALS) insider trading activity

TALS Quotes by TradingView

Susan Dana Jones is Chief Technology Officer of Talaris Therapeutics, Inc.. Currently has a direct ownership of 0 shares of TALS, which is worth approximately $0. The most recent transaction as insider was on Oct 28, 2025, when has been sold 3,152 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 0
100.0% 3M change
100.0% 12M change
Total Value Held $0

Susan Dana Jones Transaction History

Date Transaction Value Shares Traded Shares Held Form
Oct 28 2025
SELL
Sale (or disposition) back to the issuer
-
3,152 Reduced 100.0%
0 Common Stock
Oct 28 2025
SELL
Disposition due to a tender of shares in a change of control transaction
-
19,782 Reduced 86.26%
3,152 Common Stock
Oct 19 2023
BUY
Grant, award, or other acquisition
-
22,934 Added 50.0%
22,934 Common Stock
SDJ

Susan Dana Jones

Chief Technology Officer
New York, NY

Track Institutional and Insider Activities on TALS

Follow Talaris Therapeutics, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells TALS shares.

Notify only if

Insider Trading

Get notified when an Talaris Therapeutics, Inc. insider buys or sells TALS shares.

Notify only if

News

Receive news related to Talaris Therapeutics, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on TALS